If you must decide whether to sell private-company shares now or wait for a possible IPO, the choice may appear unusually straightforward when the company has several hundred million dollars in annual revenue, a documented growth path, and an active roadshow schedule. Yet late-stage pre-IPO companies often generate some of the broadest, most disputed price ranges. The issue is not missing information, but the shape of the uncertainty before entry into public markets.
The pre-IPO information paradox
Late-stage businesses can be harder to value than mid-stage ones. Because public markets are close, secondary buyers price more than present fundamentals: IPO execution risk, market timing risk, IPO offering price risk versus current expectations, and post-IPO trading behavior that no model can fully predict beforehand.
A growth-stage company with a clear revenue path can be valued using a consistent group of private-company comparables and recent funding-round data. A company one to three years from a potential IPO instead depends on an uncertain public-market result. The IPO window may close, the company may choose a direct listing or another route with different economics, or the offering may be priced at a significant discount to the last private round valuation. Each possibility expands the reasonable secondary estimate range beyond what simpler-stage companies typically face.
Public comparable analysis: uses and limits
Public comparable company analysis is the usual method for valuing late-stage private companies. In principle, it is simple: find publicly traded businesses in the same sector with similar revenue scale and growth. Apply their current EV/revenue or EV/EBITDA multiples to the private company's estimated financials, then apply a private-market illiquidity discount to produce a secondary clearing-price range.
The method performs reasonably when three conditions are true: the comparable companies closely match the target in business model and scale; their multiples are stable rather than volatile because of sector or macro pressure; and the private company's financials can be estimated with reasonable confidence. If any condition breaks down, the range can widen substantially. A frequent error is applying compressed public multiples to a private company whose last-round price was established at peak market conditions. Public markets have repriced the sector, while the last private round has not. Buyers account for that change; shareholders remain anchored to the stale round figure.
What makes up the IPO discount
Pre-IPO secondary transactions trade below the anticipated IPO price because of three separate risks. IPO execution risk covers an offering that does not happen on the expected timeline, comes in below the level assumed by the buyer, or uses a different structure. Lock-up period risk reflects the typical 180-day restriction preventing shareholders who bought before the IPO from selling into public markets after trading begins. Carrying cost is the opportunity cost of placing capital in an illiquid position during the expected period between the secondary purchase and eventual public-market sale.
The combined gap between the expected IPO price and the secondary clearing price depends on company quality, current market conditions, and demand depth for that specific name. With strong institutional interest and a near-term IPO calendar, a company may clear within 15 to 25 percent of the expected offering price. A less certain IPO path, or a sector facing weaker public-market appetite, can produce a wider discount consistent with recent market practice. These ranges describe general market dynamics, not the current price of any specific company, and are not advice on a transaction.
Price convergence near the IPO
A central feature of pre-IPO secondary pricing is convergence as the anticipated IPO date nears. After a company files its S-1 registration statement, secondary prices generally move toward the expected IPO price range because the filing materially lowers IPO execution risk. The period from S-1 filing to actual IPO pricing is often when that company's secondary price changes most quickly.
For a shareholder considering a secondary sale, convergence raises a timing choice: sell now at a discount, accepting lower proceeds in exchange for removing IPO execution uncertainty, or hold for the secondary-price increase that generally follows an S-1 filing. The decision requires a clear view of the current secondary price and the scenarios behind its possible outcomes.
IPO timing risk cuts both ways
We are not saying waiting is always better than selling early. We are saying the convergence benefit depends on the IPO arriving on the expected timeline and at or above the holder's anticipated price. If that fails, a shareholder who held through the secondary discount expecting a near-term public-market premium may instead own an asset that has returned to a wider secondary discount, with the next liquidity opportunity uncertain.
IPO windows are genuine market events. Even a company with a clear IPO path in a strong market can see its expected timeline move by 18 to 24 months when public conditions weaken. A shareholder who based the holding decision on a particular IPO timeline carries timing risk on top of the company's underlying risk. One purpose of the secondary market is to let shareholders transfer that timing risk to buyers positioned to accept it.
What pre-IPO shareholders should assess
Before making a liquidity decision, a late-stage pre-IPO shareholder should first determine the current secondary-market range for the specific share class. That range incorporates present market conditions, buyer demand for the name, and the discount assigned to remaining IPO execution uncertainty. For example, a holder at a company approaching a possible IPO can use an Earlyasset price range to compare selling now, joining a company-sponsored tender offer if available, or holding to the IPO. The range provides a concrete basis for weighing implied upside against a delayed or discounted offering.
Important: Note: This article is informational only. AI outputs are informational tools, not investment advice or formal appraisals. Private-market investments carry risks including illiquidity and loss of capital. Discount ranges here illustrate general market dynamics and do not apply to a specific company or transaction. Consult qualified financial and legal advisors before making transaction decisions.